Alex

Edgecore Networks Unveils a Powerhouse Gigabit Ethernet Switch for Versatile Deployments

The ECS4650 Series offers customers a high-capacity network infrastructure, addressing the growing demands for increased…

India Social Commerce Market Intelligence Report 2024: Global Platforms are Shutting Operations in India Amid Growing Competition in the Sector – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "India Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs…

Saviynt Appoints Identity Security Leaders to Strengthen Presence in Japan and Invest in Australia and New Zealand Channel Community

Saviynt set to accelerate growth in Japan with Masahiro Nishimura as its country manager and…

Vietnam Social Commerce Market Intelligence and Future Growth Dynamics Report, 2020-2023 and 2024-2029 Featuring Facebook, YouTube, TikTok, Instagram, and Zalo – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vietnam Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs…

Japan Social Commerce Market Intelligence and Future Growth Dynamics Report, 2020-2023 and 2024-2029 Featuring Facebook, YouTube, Line, Linktree, and Flip Fit – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs…

Iveda Philippines Targeting $5M in Smart City Advancements

Iveda’s Joint Venture to partner with 100 Philippines government units across the region to modernize…

Seclore Surges Into 2024 on the Heels of a Record-Breaking Quarter and Major Customer Wins

Seclore continues its global momentum pioneering the category of data-centric security SANTA CLARA, Calif.--(BUSINESS WIRE)--Today…

Bunjang Reveals New K-pop Merchandise Trend, with ‘ZeroBaseOne’ Coming in First

-Polaroid photo bearing signature of ‘ZB1’ member Zhang Hao was sold for KRW 1.9M (USD…

EyeBio Announces Positive Visual, Anatomic and Safety Data from First-in-Human Ph1b/2a AMARONE Trial of Restoret at Macula Society Annual Meeting

Twelve week data from the Ph1b/2a AMARONE trial reveals Restoret to be well-tolerated in patients…